The Cancer Institute's MD (Res) students train in a collaborative and multi-disciplinary environment which allows them to collaborate with clinicians, scientists performing basic research and bioinformaticians. World-class translational cancer research, in conjunction with our cancer clinical trials and hospital partners, provides exciting career opportunities for our graduates.
Modes and duration
Tuition fees (2018/19)
- £5060 (FT) £2530 (PT)
- £23540 (FT) £11760 (PT)
Note on fees: The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Current Students website.
MD(Res) students are required to have a medical degree (MBBS), or an overseas qualification of an equivalent standard. Students are usually GMC-registered and employed within the NHS.
English language requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
Research within the Cancer Institute is varied and entails various disiplines such as molecular and cellular biology, cancer genetics, immunology, genetic engineering, cancer therapeutics and bioinformatics. There are five research departments within the Cancer Institute:
- Cancer Biology
- Clinical Trials Centre
- Antibody-based therapeutics for imaging and treatment of cancer
- Brain cancer and stem cells
- Cellular and gene therapy for cancer and other blood-related disorders
- Chromosomal DNA replication and cancer
- Effects of tumour biology on therapeutic response, tumour immunology
- Genetics of Sarcoma, Acute Leukaemia, Chronic
- Leukaemia and Myoproliferative Diseases
- Medical genomics, cancer systems science and biomedical informatics
- Epigenetics and signalling networks
- Radiation biology and therapy
- Stratified/personalised cancer medicine
- Therapeutic drug-DNA interactions
- Translational projects, clinical trials and epidemiology
- Viral oncology.
Any available funded positions will be listed on the Cancer Institute's webpages. Please check the Cancer Institute website for further details.
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
Graduates go on to further medical training or clinical posts, take up PhD studies or academic posts at institutions including universities around the world. They have also found employment in laboratory management, research, industry, clinical trials co-ordination, scientific writing and editing, sales and consulting.
Skills students acquire include critical evaluation of scientific literature, experimental planning and design, interpretation of data results, presentation/public speaking skills, time management, working within a team, working independently and writing for various audiences.
Networking opportunities include weekly internal divisional seminars, weekly external speaker seminar and reception, Cancer Institute annual conference, student poster sessions, national/international research conference attendance, academic careers day and LinkedIn alumni network.
Why study this degree at UCL?
The UCL Cancer Institute offers a unique opportunity to work in a collaborative research environment that spans basic research, translational medicine and clinical applications. The Cancer Institute works closely with its associated clinical trials facilities, experimental cancer medicine centre, biobanking facilities and associated partner hospitals in London.
Department: Cancer Institute
Student / staff numbers
› 133 staff
Staff/student numbers information correct as of 1 August 2017.
Research Excellence Framework (REF)
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (world-leading) or 3* (internationally excellent)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
What our students and staff say
"UCL is a research powerhouse with an international reputation for excellence. I joined UCL to create programmes linking education and research to train the next generation of cancer scientists. Supporting students on their academic journey of discovery and development, I enjoy watching them progress in their studies, grow in confidence and move into a wide range of subject-related careers. "
Dr Julie OlszewskiCancer MSc, Cancer Institute MD(Res), Cancer Institute MPhil/PhD
UCL Cancer Institute
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Deadlines and start dates are usually dictated by funding arrangements so check with the department or academic unit to see if you need to consider these in your application preparation. You should contact the Departmental Graduate Tutor before making an application. For more information see our How to apply page.
For more information see our Applications page.Apply now